1Zissimopoulos A, Petrakis G, Stellos K, et al. Procollagen- I,collagen telopeptide I, CEA, CA 15-3 as compared to bone scintigraphy in patients with breast cancer[J]. Hell J Nucl Med,2006,9(1) :60-64. 被引量：1
4GENERAU D, BERRUTI A, TAMPELLINI M, et al. The circadian rhythm of biochemical markers of bone resorption is normally synchronized in breast cancer patients with bone lytic-metastases independently of tumor load[J]. Bone, 2007,40 ( 1 ) : 182-188. 被引量：1
5DEMERS L M. COSTA L, LIPTON A. Biochemical markers and skeletal melastases[J].Cancer Supplement, 2006,88(12) :2919-2926. 被引量：1
7Salem AM,Zohny SF,Abd El-Wahab MM,et al. Predic tive value of osteocalcin and beta-CrossLaps in metastatic breast cancer[J].Clin Bioehem, 2007,40 (16-17) : 1201- 1208. 被引量：1
8Yam am oto I, M iura H ,Kigam i Y ,et al. Detection of bone metastasis by serial measurement of C-terminal te lopeptide of type I collagen in patients with malignancy [J]. Kaku Igaku,2006,33(4) :423. 被引量：1
4HANAHAN D,FOLKMAN J.Patterns and mechanisms of the angiogenic switch tumorigenesis[J].Cell,1996,86:354-364. 被引量：1
5IMAMURA T,TAKASE M,NISHIHARA A,et al.Smad6 inhibits signaling by the TGF-β super family[J].Nature,1997,389:622-626. 被引量：1
6LIU F,HATA A,BAKER J,et al.A human Mad protein acting as BMP regulated transcriptional activator[J].Naure,1996,381(6583):620-623. 被引量：1
7Chao T Y,Yu J C,Ku C H,et al.Tartrate-resistant acid phosphatase 5b is a useful serum marker for extensive bone metastasis in breast cancer patients[J].Clin Cancer Res,2005,11(2 Pt 1):544-550. 被引量：1
8Sasaki H,Yu C Y,Dai M,et al.Elevated serum periostin levels in patients with bone metastases from breast but not lung cancer[J].Breast Cancer Res Treat,2003,77(3):245-252. 被引量：1
9Sharp J A,Sung V,Slavin J,et al.Tumor cells are the source of osteopontin and bone sialoprotein expression in human breast cancer[J].Lab Invest,1999,79(7):869-877. 被引量：1
10Bellahcene A,Kroll M,Liebens F,Castronovo V,et al.Bone sialoprotein expression in primary human breast cancer is associated with bone metastases development[J].Bone Miner Res,1996,11 (5):665-670. 被引量：1
4Muller A,Homey B,Soto H,et al.Involvement of chemokine receptors in breast cancer metastasis[J].Nature,2001,410(6824):50-56. 被引量：1
5Andre1 F,Cabioglu N,Assi1 H,et al.Expression of chemokine receptors predicts the site of metastatic relapse in patients with axillary node positive primary breast cancer[J].Ann Oncol,2006,17(6):945-951. 被引量：1
6edkamp CT, Seibert C, Peterson FC, et al. Structural basis of CXCR4 sulfotyrosine recognition by the chemokine SDF - 1/CXCL12 [ J ]. Sci Signal ,2008,1 ( 37 ) :29 - 34. 被引量：1
7Wada N, Fujisaki M, Ishli S, et al. Evalution of bone meta- bolic markers in breast cancer with bone metastasis [ J ]. Breast Cancer,2006,8(2) : 131 - 137. 被引量：1
9Yang L,Parkin DM,Ferlay J. Estimates of cancer incidence in China for 2000 and projections for 2005[J].Cancer Epidemiology Biomarkers and Prevention,2005,(01):243-250. 被引量：1
10Liska V,Holubec L Jr,Treska V. Evaluation of tumour markers as differential diagnostic tool in patients with suspicion of liver metastases from breast cancer[J].Anticancer Research,2011,(04):1447-1451. 被引量：1
